These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32552027)

  • 61. Introduction of the contraceptive implant in South Africa: Successes, challenges and the way forward.
    Mullick S; Chersich MF; Pillay Y; Rees H
    S Afr Med J; 2017 Oct; 107(10):812-814. PubMed ID: 29397679
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of Health Insurance Among Clients Seeking Contraceptive Services at Title X-Funded Facilities in 2016.
    Kavanaugh ML; Zolna MR; Burke KL
    Perspect Sex Reprod Health; 2018 Sep; 50(3):101-109. PubMed ID: 29894024
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gender norms and modern contraceptive use in urban Nigeria: a multilevel longitudinal study.
    Okigbo CC; Speizer IS; Domino ME; Curtis SL; Halpern CT; Fotso JC
    BMC Womens Health; 2018 Oct; 18(1):178. PubMed ID: 30373570
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-acting Reversible Contraception (LARC) Provision by Family Physicians: Low But on the Rise.
    Chelvakumar M; Jabbarpour Y; Coffman M; Jetty A; Glazer Shaw J
    J Am Board Fam Med; 2019; 32(1):10-12. PubMed ID: 30610136
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Role of Public-Private Partnerships to Increase Access to Contraception in an Emergency Response Setting: The Zika Contraception Access Network Program.
    Romero L; Mendoza ZV; Croft L; Bhakta R; Sidibe T; Bracero N; Malave C; Suarez A; Sanchez L; Cordero D; Lathrop E; Monroe J
    J Womens Health (Larchmt); 2020 Nov; 29(11):1372-1380. PubMed ID: 33196331
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Contraception Use by Title X Clients and Clients of Other Providers, 2015-2019.
    Wells R; Smith NK; Rodriguez MI
    Womens Health Issues; 2024; 34(1):59-65. PubMed ID: 37951782
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal.
    Sapkota S; Rajbhandary R; Lohani S
    Matern Child Health J; 2017 Sep; 21(9):1713-1723. PubMed ID: 26955996
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Unintended pregnancy and subsequent postpartum long-acting reversible contraceptive use in Zimbabwe.
    Nance N; Ralph L; Padian N; Cowan F; Buzdugan R; Mushavi A; Mahomva A; McCoy SI
    BMC Womens Health; 2018 Nov; 18(1):193. PubMed ID: 30477497
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Factors associated with long-acting and short-acting reversible contraceptive use in Ethiopia: an analysis of the 2016 Demographic and Health Survey.
    Stonehill A; Bishu SG; Taddese HB
    Eur J Contracept Reprod Health Care; 2020 Oct; 25(5):350-358. PubMed ID: 32677852
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Temporal Trends in the Uptake and Continuation of the Etonogestrel Implant in a Large Private Practice Setting.
    Howard DL; Ford A; Ceballos S; Volker KW
    J Womens Health (Larchmt); 2018 Feb; 27(2):191-195. PubMed ID: 28976797
    [TBL] [Abstract][Full Text] [Related]  

  • 71. From awareness to usage of long-acting reversible contraceptives: Results of a large European survey.
    Caetano C; Bliekendaal S; Engler Y; Lombardo M
    Int J Gynaecol Obstet; 2020 Dec; 151(3):366-376. PubMed ID: 32852798
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Is low income a constraint to contraceptive use among the Pakistani poor?
    Agha S
    J Biosoc Sci; 2000 Apr; 32(2):161-75. PubMed ID: 10765608
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Determinants of long acting contraceptive utilization among HIV positive reproductive age women attending care at art clinics of public health facilities in Arba Minch town, Southern Ethiopia, 2019: a case control study.
    Yirsaw B; Gebremeskel F; Gebremichael G; Shitemaw T
    AIDS Res Ther; 2020 Jun; 17(1):34. PubMed ID: 32539743
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Patients' experiences with South Carolina's immediate postpartum Long-acting reversible contraception Medicaid policy.
    Mann ES; White AL; Rogers PL; Gomez AM
    Contraception; 2019 Aug; 100(2):165-171. PubMed ID: 31028752
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Collaboratively seeking to improve contraceptive counselling at the time of an abortion: a case study of quality improvement efforts in Sweden.
    Kilander H; Brynhildsen J; Alehagen S; Fagerkrantz A; Thor J
    BMJ Sex Reprod Health; 2019 Jul; 45(3):190-199. PubMed ID: 31289100
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of unintended pregnancy at 12 months between two contraceptive care programs; a controlled time-trend design.
    Madden T; Paul R; Maddipati R; Buckel C; Goodman M; Peipert JF
    Contraception; 2019 Sep; 100(3):196-201. PubMed ID: 31132346
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of staff training and cost support on provision of long-acting reversible contraception in community health centers.
    Buckel C; Maddipati R; Goodman M; Peipert JF; Madden T
    Contraception; 2019 Apr; 99(4):222-227. PubMed ID: 30685287
    [TBL] [Abstract][Full Text] [Related]  

  • 78. From theory to application: using performance measures for contraceptive care in the Title X family planning program.
    Loyola Briceno AC; Kawatu J; Saul K; DeAngelis K; Frederiksen B; Moskosky SB; Gavin L
    Contraception; 2017 Sep; 96(3):166-174. PubMed ID: 28689021
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.
    Chappell CA; Harkoo I; Szydlo DW; Bunge KE; Singh D; Nakabiito C; Mhlanga F; Kamira B; Piper JM; Balkus JE; Hillier SL;
    Contraception; 2019 Sep; 100(3):214-218. PubMed ID: 31226323
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Contraceptive Method Use and Chlamydia Positivity Among California Family Planning Clients: The Case for New Multipurpose Prevention Technologies.
    Hunter LA; Nelson L; Chow JM; Holt BY; Bauer HM
    J Womens Health (Larchmt); 2018 Jun; 27(6):768-774. PubMed ID: 29377757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.